Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

$100 Invested In Automatic Data Processing 20 Years Ago Would Be Worth This Much Today

Automatic Data Processing (NASDAQ:ADP) has outperformed the market over the past 20 years by 1.36% on an annualized basis producing an average annual return of 8.84%. Currently, Automatic Data Processing has a market capitalization of $98.80 billion.
byBenzinga Insights
October 25, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Automatic Data Processing (NASDAQ:ADP) has outperformed the market over the past 20 years by 1.36% on an annualized basis producing an average annual return of 8.84%. Currently, Automatic Data Processing has a market capitalization of $98.80 billion.

Buying $100 In ADP: If an investor had bought $100 of ADP stock 20 years ago, it would be worth $559.53 today based on a price of $237.90 for ADP at the time of writing.

Automatic Data Processing’s Performance Over Last 20 Years

comp_fig

Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

cbdMD Reports YoY Dip In Q1 Net Sales, Shrinks Operating Loss, Expands Into Hemp And Mushroom Products Markets

By Jelena Martinovic
February 14, 11:03 AM
Medical cannabis company cbdMD has reported financial results for its first quarter of fiscal 2024. Operating loss improved to $1.1m compared to $4.1m for the same period in the previous year. Gross profit was flat at around $3.5m, while operating expenses were $4.6m, down from $7.6m in the previous year. Total net sales declined to $5.37m from almost $6m in the corresponding prior-year period. Direct-to-consumer net sales represented 82.3% of total net sales, a decrease from 90% in Q1 2023. On 31 December 2023, cbdMD had total working capital of roughly $1.4m compared to approximately $3.4m on 30 September, with cash on hand dropping to roughly $1.5m from $1.8m over the same period. The Charlotte-based company recently struck a securities purchase agreement with five institutional investors to fund the national rollout of its ATRx Labs functional mushroom products, as well as launching the hempMD and ATRx Labs brands.

YCBD